U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C10H7NO2
Molecular Weight 173.1681
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of QUINALDIC ACID

SMILES

OC(=O)C1=CC=C2C=CC=CC2=N1

InChI

InChIKey=LOAUVZALPPNFOQ-UHFFFAOYSA-N
InChI=1S/C10H7NO2/c12-10(13)9-6-5-7-3-1-2-4-8(7)11-9/h1-6H,(H,12,13)

HIDE SMILES / InChI

Molecular Formula C10H7NO2
Molecular Weight 173.1681
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
catena-Poly[[diaqua-calcium(II)]-bis-(μ-quinoline-3-carboxyl-ato)].
2010-10-23
Mechanism for the formation of substituted manganese(V) cyanidonitrido complexes: crystallographic and kinetic study of the substitution reactions of trans-[MnN(H2O)(CN)4]2- with monodentate pyridine and bidentate pyridine-carboxylate ligands.
2010-10-18
Carboxylate tolerance of the redox-active platform [Ru(mu-tppz)Ru](n), where tppz = 2,3,5,6-tetrakis(2-pyridyl)pyrazine, in the electron-transfer series [(L)ClRu(mu-tppz)RuCl(L)](n), n = 2+, +, 0, -, 2-, with 2-picolinato, quinaldato, and 8-quinolinecarboxylato ligands (L(-)).
2010-07-19
Bis(μ-quinoline-2-carboxyl-ato)-κN,O:O;κO:N,O-bis-[(acetato-κO,O')(methanol-κO)lead(II)].
2010-07-17
(Quinoline-2-carboxyl-ato-κO)(quinoline-2-carb-oxy-lic acid-κO)bis-(quinoline-2-carb-oxy-lic acid-κN,O)potassium.
2010-07-17
Chloridomethyl-phen-yl(quinoline-2-carboxyl-ato-κN,O)tin(IV).
2010-07-17
Bis(quinoline-2-carboxyl-ato-κN,O)lead(II).
2010-07-17
CODA: accurate detection of functional associations between proteins in eukaryotic genomes using domain fusion.
2010-06-01
A new scaffold of an old protein fold ensures binding to the bisintercalator thiocoraline.
2010-03-26
Circulating Antibodies to IDO/THO Pathway Metabolites in Alzheimer's Disease.
2010-03-15
2-(Methoxy-carbon-yl)quinolinium tetra-chlorido(quinoline-2-carboxyl-ato-κN,O)stannate(IV) methanol solvate.
2010-03-10
Coordinatively polymeric and monomeric bismuth(III) complexes with pyridine carboxylic acids.
2010-02-28
Synthesis and characterization of iron(II) quinaldate complexes.
2010-02-01
The Ayurvedic drug, Ksheerabala, ameliorates quinolinic acid-induced oxidative stress in rat brain.
2010-01
Methyl 6-chloro-2-methyl-4-phenyl-quinoline-3-carboxyl-ate.
2009-12-16
Guanidinium quinoline-2-carboxyl-ate.
2009-11-25
Novel inorganic host layered double hydroxides intercalated with guest organic inhibitors for anticorrosion applications.
2009-10
Supramolecular stores of acetic acid--an alternative for metal-organic frameworks.
2009-09-30
Transcriptional profiling of rats subjected to gestational undernourishment: implications for the developmental variations in metabolic traits.
2009-09-29
A simple and convenient copper-catalyzed tandem synthesis of quinoline-2-carboxylates at room temperature.
2009-08-07
Synthesis, characterization and crystal structure of novel mononuclear peroxotungsten(VI) complexes. Insulinomimetic activity of W(VI) and Nb(V) peroxo complexes.
2009-05
Thiostrepton biosynthesis: prototype for a new family of bacteriocins.
2009-04-01
The natural xanthone alpha-mangostin reduces oxidative damage in rat brain tissue.
2009-02
The physiological action of picolinic Acid in the human brain.
2009
Iron-catalysed aziridination reactions promoted by an ionic liquid.
2008-12-07
Pharmacokinetics, metabolism, and excretion of torcetrapib, a cholesteryl ester transfer protein inhibitor, in humans.
2008-11
trans-Bis(methanol-κO)bis-(quinoline-2-carboxyl-ato-κN,O)manganese(II).
2008-10-11
3,7-Dichloro-quinoline-8-carboxylic acid.
2008-08-20
Diaqua-bis(3,7-dichloro-quinoline-8-carboxyl-ato)zinc(II) monohydrate.
2008-08-16
(Benzoato-κO,O')(quinoline-2-carboxyl-ato-κN,O)(quinoline-2-carboxylic acid-κN,O)copper(II).
2008-05-21
One-dimensional hydrogen-bonded structures in the 1:1 proton-transfer compounds of 4,5-dichlorophthalic acid with 8-hydroxyquinoline, 8-aminoquinoline and quinoline-2-carboxylic acid (quinaldic acid).
2008-03
2-(Ethoxy-carbon-yl)quinolinium butyl-trichlorido(quinoline-2-carboxyl-ato-κN,O)stannate(IV).
2008-01-04
(Benzoato-κO,O')(quinoline-2-carboxyl-ato-κN,O)(quinoline-2-carboxylic acid-κN,O)manganese(II).
2007-12-21
Di-μ(3)-oxido-bis-(μ(2)-quinaldato-κO:O)-bis-(quinaldato-κN,O)tetra-kis[di-n-butyl-tin(IV)].
2007-12-18
2-Carboxy-quinolinium-2,4,6-trinitro-benzene-sulfonate-quinolinium-2-carboxyl-ate (1/1/1).
2007-12-06
catena-Poly[[trimethyl-tin(IV)]-μ-quinaldato].
2007-12-06
Hydrogen-bonded frameworks of bis(2-carboxypyridinium) hexafluorosilicate and bis(2-carboxyquinolinium) hexafluorosilicate dihydrate.
2007-09
4-Carboxyanilinium (2R,3R)-tartrate and a redetermination of the alpha-polymorph of 4-aminobenzoic acid.
2007-09
Synthesis and characterisation of luminescent fluorinated organoboron compounds.
2007-04-14
Proton-transfer and non-transfer in compounds of quinoline and quinaldic acid with L-tartaric acid.
2006-12
Luminescence tuning of organoboron quinolates through substituent variation at the 5-position of the quinolato moiety.
2006-11-09
Random mutagenesis in Corynebacterium glutamicum ATCC 13032 using an IS6100-based transposon vector identified the last unknown gene in the histidine biosynthesis pathway.
2006-08-10
Prooxidant action of xanthurenic acid and quinoline compounds: role of transition metals in the generation of reactive oxygen species and enhanced formation of 8-hydroxy-2'-deoxyguanosine in DNA.
2006-08
Biochemical characterization of recombinant dihydroorotate dehydrogenase from the opportunistic pathogenic yeast Candida albicans.
2006-07
Discovering functional gene expression patterns in the metabolic network of Escherichia coli with wavelets transforms.
2006-03-08
Characterization and inhibition of SARS-coronavirus main protease.
2006
Stereocontrolled synthesis of the quinaldic acid macrocyclic system of thiostrepton.
2002-06-03
[Synthesis and biological properties of pyrimidine 2'-deoxynucleosides modified by a residue of quinaldic acid].
1995-08
The role of dietary ergothioneine in the development of diabetes mellitus.
1982-08
Inhibition effect of quinaldic acid on glucose-induced insulin release from isolated Langerhans islets of the rat.
1974-07-24
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:34:08 GMT 2025
Edited
by admin
on Mon Mar 31 19:34:08 GMT 2025
Record UNII
P90NWT719R
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-4882
Preferred Name English
QUINALDIC ACID
MI  
Common Name English
QUINALDIC ACID [MI]
Common Name English
2-QUINOLINECARBOXYLIC ACID
Systematic Name English
Code System Code Type Description
PUBCHEM
7124
Created by admin on Mon Mar 31 19:34:08 GMT 2025 , Edited by admin on Mon Mar 31 19:34:08 GMT 2025
PRIMARY
FDA UNII
P90NWT719R
Created by admin on Mon Mar 31 19:34:08 GMT 2025 , Edited by admin on Mon Mar 31 19:34:08 GMT 2025
PRIMARY
NSC
4882
Created by admin on Mon Mar 31 19:34:08 GMT 2025 , Edited by admin on Mon Mar 31 19:34:08 GMT 2025
PRIMARY
MERCK INDEX
m9432
Created by admin on Mon Mar 31 19:34:08 GMT 2025 , Edited by admin on Mon Mar 31 19:34:08 GMT 2025
PRIMARY Merck Index
CHEBI
18386
Created by admin on Mon Mar 31 19:34:08 GMT 2025 , Edited by admin on Mon Mar 31 19:34:08 GMT 2025
PRIMARY
DRUG BANK
DB02428
Created by admin on Mon Mar 31 19:34:08 GMT 2025 , Edited by admin on Mon Mar 31 19:34:08 GMT 2025
PRIMARY
MESH
C008898
Created by admin on Mon Mar 31 19:34:08 GMT 2025 , Edited by admin on Mon Mar 31 19:34:08 GMT 2025
PRIMARY
CAS
93-10-7
Created by admin on Mon Mar 31 19:34:08 GMT 2025 , Edited by admin on Mon Mar 31 19:34:08 GMT 2025
PRIMARY
ECHA (EC/EINECS)
202-218-3
Created by admin on Mon Mar 31 19:34:08 GMT 2025 , Edited by admin on Mon Mar 31 19:34:08 GMT 2025
PRIMARY
EPA CompTox
DTXSID6059079
Created by admin on Mon Mar 31 19:34:08 GMT 2025 , Edited by admin on Mon Mar 31 19:34:08 GMT 2025
PRIMARY